What is StudyMetrix Research?
StudyMetrix Research operates as an independent research clinic dedicated to advancing medical science through Phase II-IV clinical trials. The organization prioritizes a volunteer-centered approach, ensuring participants receive personalized support throughout their involvement in trials for various medical conditions. By focusing on innovative treatments and enhancing the efficiency of drug development, StudyMetrix Research plays a crucial role in bringing life-changing medical discoveries from concept to reality.
How much funding has StudyMetrix Research raised?
StudyMetrix Research has raised a total of $110K across 1 funding round:
Debt
$110K
Debt (2021): $110K with participation from PPP
Key Investors in StudyMetrix Research
PPP
Public-Private Partnership
What's next for StudyMetrix Research?
The recent strategic investment signals StudyMetrix Research's readiness for accelerated growth and enhanced operational capacity. As a late-stage entity, the company is poised to leverage this capital infusion to expand its trial offerings, potentially explore new therapeutic areas, and further solidify its reputation as a key player in clinical research. This backing is expected to fuel advancements in patient care and contribute significantly to the broader pharmaceutical and biotechnology landscape.
See full StudyMetrix Research company page
